找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Therapeutic Targets; John L. Marshall Reference work 2017 Springer Science+Business Media New York 2017 Anti-angiogenic Targets.HER

[复制链接]
楼主: 迅速
发表于 2025-3-30 12:13:29 | 显示全部楼层
发表于 2025-3-30 12:21:36 | 显示全部楼层
CD4+ T Cellsn generating anti-tumor CD4+ T cell responses have been met with limited success. However, new approaches including Chimeric Antigen Receptors (CARs) may be increase the viability of CD4+ T cells as a potential therapeutic modality in the treatment of cancer.
发表于 2025-3-30 17:05:57 | 显示全部楼层
发表于 2025-3-30 22:23:19 | 显示全部楼层
发表于 2025-3-31 03:08:56 | 显示全部楼层
发表于 2025-3-31 05:28:46 | 显示全部楼层
发表于 2025-3-31 09:57:11 | 显示全部楼层
发表于 2025-3-31 15:53:49 | 显示全部楼层
发表于 2025-3-31 20:17:49 | 显示全部楼层
https://doi.org/10.1007/978-3-662-38531-9d on normal granulocytes (Engvall et al., Proc Natl Acad Sci U S A 75:1670–1674, 1978). As an intercellular adhesion molecule, CEA may contribute to the formation of metastasis; there is a correlation between serum CEA in patients with cancer and the incidence of hepatic metastases, but this could a
发表于 2025-4-1 00:47:38 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-18 05:20
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表